Wegovy & Zepbound Cutting Prices For Some

(AP) – Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of $499 takes effect immediately. The new pricing is available to both the uninsured and people who have insurance that doesn’t cover the weight-loss drugs. Last week, rival Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is making larger doses available for $499 through its self-pay program.